Self Treatment of Opioid Withdrawal Using Kratom (Mitragynia speciosa korth)

It is widely known amongst people “in the know” that kratom is undoubtedly the miracle plant that helps so many ailments. Perhaps none more astonishing, than opioid withdrawals. Today, we highlight a documented study by NCBI.

The DEA / FDA has had kratom in its cross-hairs for some time and has become a big nasty, frustrating thorn in big pharma’s derriere. Kratom is delivering incredible relief for people that have opioid addictions.

However, I digress. The purpose of this article is to provide information of a well-documented study of a 43-year old man with generalized tonic-clonic seizures and as a side note, was battling withdrawals from his prescribed opioids. This is a quick story of how kratom was used in a self-care setting, to assist in his withdrawls from opioids.

Kratom (Mitragynia speciosa korth) is a medicinal herb indigenous to Southeast Asia whose components mitragynine and 7-hydroxymitragynine agonize the mu-opioid receptor with high affinity. Recent findings suggest that kratom is purchased from internet sources by some of the 40 million Americans with chronic pain to self-manage opioid withdrawal. Unfortunately, the reasons underlying this practice, its efficacy or adverse effects are poorly understood. We present a case of kratom used to self-manage chronic pain and opioid withdrawal complicated by a potential interaction with modafinil.

Kratom has become widely known (in a closed setting) to lessen the effects of opioid withdrawals. This of course, is an albatross of the worst kind to the pharmaceutical industry, and is screaming to get out to the public. There’s ample information to back up this claim, just do a basic “google” search to find case after case.

A 43-year-old male was admitted for evaluation of a generalized tonic-clonic seizure. His medical history included chronic pain from thoracic outlet syndrome treated with hydromorphone. As his tolerance escalated, he began injecting subcutaneously 10 mg hydromorphone per day from crushed pills. During periods when hydromorphone was unavailable, he managed opioid withdrawal with kratom purchased from internet vendors.

Kratom was a side note in this study, but in our interest, a very significant one. As noted in the story, kratom was a declared “self-care” item but, was included in the overall care.

Approximately 3.5 years before presentation, social stressors compelled him to quit hydromorphone abruptly. He again averted opioid withdrawal by ingesting a tea made from kratom four times a day.The patient attributed substantial pain relief to kratom as well as improved alertness. He did not, however, experience the drowsiness that often accompanied opioid use. He spent $15 000 per year on kratom, a sum confirmed by his wife.

Ingesting kratom via tea four times per day averted the withdrawal effects significantly. Nobody we might add, would spend $15k/year if there was no positive effects.

Adverse effects from kratom are poorly described. Although mitragynines agonize mu-opioid receptors, respiratory depression, coma, pulmonary edema and death have not, to our knowledge, been associated with human kratom ingestion.

As noted, kratom continues to be a “poorly described” element. However, this study confirms on a small scale of how kratom can help the quality of life to many but, is lost in the vastness of the internet. There is study after study, that proves kratom assists people get off opioids. We desperately hope this changes in the future… before it is taken away completely.

Why kratom is consistently hidden “behind the curtain” is a mystery to us all, but we must continue the fight to liberate this wonderful plant. Keep up the good fight!

RESOURCES:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670991/#R1